I don't understand how the deal with Roslin is not affecting the PPS. This deal has greatly increased potential prospects. Though, I guess they have not really landed any commercial or academic ventures; just partnership with another firm to help them broaden their clientele.
Also, will ACTC give updates on how the trials are going or will they not release any statements about the trials into the final results are in and the trials are over?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.